Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03207256
Title Compassionate Use Trial of Ublituximab and TGR-1202 in Combination or as Single Agents in Subjects Currently Receiving Treatment on Ublituximab and/or TGR-1202 Trials
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors TG Therapeutics, Inc.
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805 United States Details
TG Therapeutics Investigational Trial Site Tucson Arizona 85711 United States Details
TG Therapeutics Investigational Trial Site Fayetteville Arkansas 72703 United States Details
TG Therapeutics Investigational Trial Site Duarte California 91010 United States Details
TG Therapeutics Investigational Trial Site Fort Myers Florida 33901 United States Details
TG Therapeutics Investigational Trial Site Atlanta Georgia 30322 United States Details
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46804 United States Details
TG Therapeutics Investigational Trial Site Coon Rapids Minnesota 55433 United States Details
TG Therapeutics Investigational Trial Site Omaha Nebraska 68198 United States Details
TG Therapeutics Investigational Trial Site Durham North Carolina 27710 United States Details
TG Therapeutics Investigational Site Canton Ohio 44718 United States Details
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45242 United States Details
TG Therapeutics Investigational Trial Site Nashville Tennessee 37203 United States Details
TG Therapeutics Investigational Trial Site Denton Texas 76210 United States Details
TG Therapeutics Investigational Trial Site San Antonio Texas 78229 United States Details
TG Therapeutics Investigational Trial Site Seattle Washington 98104 United States Details
TG Therapeutics Investigational Trial Site Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field